v3.26.3
Income Taxes
9 Months Ended
Sep. 30, 2026
Income Tax Disclosure [Abstract]  
Income Taxes
9.
Income Taxes

The components of income (loss) before taxes, as shown in the accompanying Financial Statements, consisted of the following for the three and nine months ended September 30, 2026 and 2025:

 

 

Three Months Ended
September 30,

 

 

Nine Months Ended
September 30,

 

 

2026

 

 

2025

 

 

2026

 

 

2025

 

 

(Amounts in thousands)

 

Income (loss) before income taxes:

 

 

 

 

 

 

 

 

 

 

 

 

Domestic

 

$

(220

)

 

$

791

 

 

$

(529

)

 

$

(2,213

)

Foreign

 

 

470

 

 

 

444

 

 

 

1,434

 

 

 

1,896

 

          Income (loss) before income taxes:

 

$

250

 

 

$

1,235

 

 

$

905

 

 

$

(317

)

 

 

 

 

 

 

 

 

 

 

 

 

 

 

The Company has foreign subsidiaries that generate revenues from non-U.S.-based clients and provide services to the Company’s U.S. operations. As a result, a portion of the Company's earnings is subject to the foreign tax jurisdictions, which may have tax rates that differ from those in the United States.

The provision (benefit) for income taxes, as shown in the accompanying Financial Statements, consisted of the following for the three and nine months ended September 30, 2026 and 2025:

 

 

Three Months Ended
September 30,

 

 

Nine Months Ended
September 30,

 

 

2026

 

 

2025

 

 

2026

 

 

2025

 

 

(Amounts in thousands)

 

Current provision (benefit):

 

 

 

 

 

 

 

 

 

 

 

 

Federal

 

$

(31

)

 

$

(179

)

 

$

(478

)

 

$

(442

)

State

 

 

19

 

 

 

13

 

 

 

(2

)

 

 

(35

)

Foreign

 

 

228

 

 

 

250

 

 

 

522

 

 

 

689

 

Total current provision (benefit)

 

 

216

 

 

 

84

 

 

 

42

 

 

 

212

 

Deferred provision (benefit):

 

 

 

 

 

 

 

 

 

 

 

 

Federal

 

 

44

 

 

 

245

 

 

 

649

 

 

 

(116

)

State

 

 

7

 

 

 

49

 

 

 

110

 

 

 

(18

)

Foreign

 

 

(24

)

 

 

(90

)

 

 

(67

)

 

 

(32

)

Total deferred provision (benefit)

 

 

27

 

 

 

204

 

 

 

692

 

 

 

(166

)

Change in valuation allowance

 

 

-

 

 

 

6

 

 

 

-

 

 

 

-

 

Total provision (benefit) for income taxes

 

$

243

 

 

$

294

 

 

$

734

 

 

$

46

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

The reconciliation of income taxes computed using the statutory U.S. income tax rate and the provision (benefit) for income taxes for the three and nine months ended September 30, 2026 and 2025, were as follows (amounts in thousands):

 

(Amounts in thousands)

 

Three Months Ended
September 30, 2026

 

 

Three Months Ended
September 30, 2025

 

Income taxes computed at the federal statutory rate

 

$

53

 

 

 

21.0

%

 

$

259

 

 

 

21.0

%

State income taxes, net of federal tax benefit

 

 

26

 

 

 

10.4

 

 

 

64

 

 

 

5.2

 

Stock-based compensation shortfalls

 

 

0

 

 

 

—

 

 

 

163

 

 

 

13.2

 

Non-deductible executive compensation

 

 

63

 

 

 

25.2

 

 

 

—

 

 

 

—

 

Difference in income tax rate on foreign
   earnings/other

 

 

101

 

 

 

40.6

 

 

 

(198

)

 

 

(16.1

)

Change in valuation allowance

 

 

—

 

 

 

—

 

 

 

6

 

 

 

0.5

 

 

$

243

 

 

 

97.2

%

 

$

294

 

 

 

23.8

%

 

 

 

(Amounts in thousands)

 

Nine Months Ended
September 30, 2026

 

 

Nine Months Ended
September 30, 2025

 

Income taxes computed at the federal statutory rate

 

$

190

 

 

 

21.0

%

 

$

(67

)

 

 

(21.0

)%

State income taxes, net of federal tax benefit

 

 

108

 

 

 

11.9

 

 

 

(51

)

 

 

(16.1

)

Stock-based compensation shortfalls

 

 

116

 

 

 

12.8

 

 

 

155

 

 

 

48.9

 

Non-deductible executive compensation

 

 

206

 

 

 

22.8

 

 

 

—

 

 

 

—

 

Difference in income tax rate on foreign
   earnings/other

 

 

114

 

 

 

12.6

 

 

 

9

 

 

 

2.7

 

 

$

734

 

 

 

81.1

%

 

$

46

 

 

 

14.5

%

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

As of September 30, 2026 and December 31, 2025, the Company maintained a valuation allowance of approximately $435,000 against net operating losses in Ireland and the United Kingdom that may not be realized.